Varinos

BiotechnologySeries DTokyo, Japanvarinos.com

Latest round

Series D

Last raised

Mar 2026

Total raised

$7.3M

Investors

10

About Varinos

a Varinos, a startup specializing in genome analysis. The company develops and offers clinical tests that leverage genomic technology for infertility treatments in reproductive medicine, dental care abroad, and personalized medicine. In March 2026, Varinos Inc. Varinos???? specializes in the development and clinical implementation of genetic testing solutions utilizing advanced genomic technologies. The company's core product offerings include a range of genetic tests focused on infertility, reproductive health, and microbiome analysis, particularly uterine flora assessments and preimplantation genetic testing. These services aim to address societal issues such as infertility and declining birth rates by providing personalized insights that assist families in making informed decisions regarding their reproductive health. Varinos serves healthcare providers, fertility clinics, and individual consumers, delivering tailored genomic information that aids in understanding and interpreting specific genetic results.The revenue model of Varinos???? is structured around direct-to-consumer sales and B2B partnerships with healthcare providers and fertility clinics. Clients engage with the firm through purchasing specific genetic testing services or partnering for comprehensive analysis solutions. Transactions typically involve individual payments for services rendered, such as uterine flora tests and preimplantation genetic tests, tailored to the unique needs of each client. Pricing structures are designed to provide accessible solutions for different consumer segments while ensuring high-quality and precise testing outcomes. Additionally, ongoing collaborations with medical professionals enhance the company's outreach and service offerings, reinforcing its position in the reproductive health market.

Who invested in Varinos

10 investors across 3 rounds

See all investors in Varinos

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Mar 31, 2026

    Amount

    Undisclosed

    Investors

    Locked

  2. Series C

    Aug 3, 2022

    Amount

    $4.4M

    Investors

    Locked

  3. Series B

    Sep 25, 2020

    Amount

    $2.9M

    Investors

    Locked

Questions about Varinos

Who invested in Varinos?

Varinos has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Varinos raised?

Varinos has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Varinos last raise money?

Varinos's most recent round on record is a Series D, in Mar 2026.

What does Varinos do?

a Varinos, a startup specializing in genome analysis.

Where is Varinos headquartered?

Varinos is headquartered in Tokyo, Japan.

Which VCs invest in companies like Varinos?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Varinos's stage. Their profiles are linked below.

Raising like Varinos? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.